| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Integrative Physiology |
From Molecular Cardiology (T.Z., C.-H.Y., T.T., M.M.-R., G.C., C.U., A.M.Z., S.D.), Department of Internal Medicine III, University Frankfurt; Max Planck Institute (A.W., T.B.), Bad Nauheim; Junior Group Molecular Imaging (F.K.), German Cancer Research Center, Heidelberg; Angewandte Virologie und Gentherapie (S.S., M.G.), Georg-Speyer-Haus, Frankfurt; and Gemeinschaftspraxis für Pathologie (C.I.), Frankfurt, Germany.
Correspondence to Prof Dr Stefanie Dimmeler Molecular Cardiology, Department of Internal Medicine III University of Frankfurt, Theodor-Stern-Kai 7 60590 Frankfurt am Main, Germany. E-mail Dimmeler{at}em.uni-frankfurt.de
Circulating blood–derived vasculogenic cells improve neovascularization of ischemic tissue by a broad repertoire of potential therapeutic actions. Whereas initial studies documented that the cells incorporate and differentiate to cardiovascular cells, other studies suggested that short-time paracrine mechanisms mediate the beneficial effects. The question remains to what extent a physical incorporation is contributing to the beneficial effects of cell therapy. By using the inducible suicide gene thymidine kinase to deplete transplanted cells, we determined the contribution of physical incorporation in 3 animal models. After acute myocardial infarction, depletion of cells 14 days after infusion resulted in a reduction of capillary density and a substantial deterioration of heart function. Likewise, neovascularization of Matrigel plugs and ischemic limbs was significantly suppressed when infused cells were depleted 7 days after infusion. Induction of cell death in the previously transplanted cells reduced perfusion and led to vascular leakage as evidenced by Evans blue extravasation. These results indicate that physical incorporation and persistence of cells contribute to cell-mediated improvement of neovascularization and cardiac function. Long-term paracrine activities and/or cell intrinsic mechanisms may have contributed to the maintenance of functional improvement.
Key Words: progenitor cells neovascularization cell therapy
Related Article:
Circ. Res. 2008 103: 1200-1201.
This article has been cited by other articles:
![]() |
E. J. Suuronen, P. Zhang, D. Kuraitis, X. Cao, A. Melhuish, D. McKee, F. Li, T. G. Mesana, J. P. Veinot, and M. Ruel An acellular matrix-bound ligand enhances the mobilization, recruitment and therapeutic effects of circulating progenitor cells in a hindlimb ischemia model FASEB J, May 1, 2009; 23(5): 1447 - 1458. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Scharner, L. Rossig, G. Carmona, E. Chavakis, C. Urbich, A. Fischer, T.-B. Kang, D. Wallach, Y. J. Chiang, Y. L. Deribe, et al. Caspase-8 Is Involved in Neovascularization-Promoting Progenitor Cell Functions Arterioscler. Thromb. Vasc. Biol., April 1, 2009; 29(4): 571 - 578. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Sussman Showing up Isn't Enough for Vascularization: Persistence Is Essential Circ. Res., November 21, 2008; 103(11): 1200 - 1201. [Full Text] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2008 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |